|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.25 CNY | -1.99% |
|
+4.74% | +1.05% |
| 07-07 | Yiling Pharma Gets Nod to Market Irbesartan | MT |
| 06-29 | Shijiazhuang Yiling Pharmaceutical Subsidiary Gets China Nod for Erectile Dysfunction Drug | MT |
Executive Committee: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Manager | Positions heldSince | ||
|---|---|---|---|
Xiang Jun Wu 51 year |
| ||
Chen Guang Li 53 year |
| ||
Rui Wu 46 year |
| ||
Hua Wang |
|
Composition of the Board of Directors: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Director | CommitteesSince | ||||
|---|---|---|---|---|---|
Yi Ling Wu 77 year |
| ||||
Zhen Wang 53 year |
| ||||
Xiao Han Liu 71 year |
| ||||
Pei Yong Gao 61 year |
| ||||
Wei Dong Xu 58 year |
| ||||
Qiu Lian Zhang 56 year |
| ||||
Gen Wu Liu 53 year |
| ||||
Rui Wu 46 year |
| ||||
Rui Hua Niu 47 year |
| ||||
Xue Dong Gao 56 year |
| ||||
Chen Guang Li 53 year |
| ||||
Xiang Jun Wu 51 year |
|
Latest Appointments: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Former Officers and Directors: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
|
Age distribution of managers
Parity Men Women
| Male | 12 |
|---|---|
| Female | 2 |
Of which Executive Committee
| Male | 4 |
|---|---|
| Female | 0 |
Of which Directors
| Male | 10 |
|---|---|
| Female | 2 |
Revisions
ESG MSCI
Departures of Key Persons
Chairman
2007-12-31 2014-08-18
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















